Zobrazeno 1 - 10
of 399
pro vyhledávání: '"Fagerli UM"'
Autor:
Dahl AA; National Advisory Unit for Late Effects after Cancer Therapy, Oslo University Hospital, Oslo, Norway. alvdah@ous-hf.no.; Department of Oncology, Oslo University Hospital, Oslo, Norway. alvdah@ous-hf.no., Smeland KB; National Advisory Unit for Late Effects after Cancer Therapy, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Eikeland S; National Advisory Unit for Late Effects after Cancer Therapy, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Fagerli UM; Department of Oncology, St Olav's Hospital, Trondheim, Norway., Bersvendsen HS; Department of Oncology, University Hospital of Northern Norway, Tromsø, Norway., Fosså A; Department of Oncology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Center for B-Cell Malignancies, University of Oslo, Oslo, Norway., Kiserud CE; National Advisory Unit for Late Effects after Cancer Therapy, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Publikováno v:
Journal of cancer survivorship : research and practice [J Cancer Surviv] 2024 Dec; Vol. 18 (6), pp. 1921-1930. Date of Electronic Publication: 2023 Aug 01.
Autor:
Dahl AA; National Advisory Unit for Late Effects after Cancer Therapy, Oslo University Hospital, Oslo, Norway. alvandreas@msn.com., Smeland KB; National Advisory Unit for Late Effects after Cancer Therapy, Oslo University Hospital, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo, Norway., Eikeland S; National Advisory Unit for Late Effects after Cancer Therapy, Oslo University Hospital, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo, Norway., Fagerli UM; Department of Oncology, St Olav's Hospital, Trondheim, Norway; Institute of Clinical and Molecular Medicine, NTNU, Trondheim, Norway., Bersvendsen HS; Department of Oncology, University Hospital of Northern Norway, Tromsø, Norway., Fosså A; Department of Oncology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B-cell malignancies, University of Oslo, Oslo, Norway., Kiserud CE; National Advisory Unit for Late Effects after Cancer Therapy, Oslo University Hospital, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Publikováno v:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2024 Aug 04; Vol. 63, pp. 600-606. Date of Electronic Publication: 2024 Aug 04.
Autor:
Pulczynski EJ; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark; Department of Haematology, Region Hospital Goedstrup, Herning., Simonsen MR; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; Department of Mathematical Sciences, Aalborg University, Aalborg., Kuittinen O; Department of Oncology, Kuopio University Hospital Cancer Center, Kuopio, Finland; Faculty of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio., Fagerli UM; Department of Oncology, St Olav University Hospital, Trondheim, Norway; Department of Clinical and Molecular Medicine, Norwegian University of science and technology (NTNU), Trondheim, Norway., Erlanson M; Department of Radiation Sciences, Umeå University, Umeå, Sweden., Fluge Ø; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway., Leppä S; Research Programs Unit/Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki., Østenstad B; Department of Oncology, Oslo University Hospital, Oslo, Norway., Fosså A; Department of Oncology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B-cell Malignancies, University of Oslo, Oslo, Norway., Eriksson M; Department of Oncology, Skane University Hospital, Lund, Sweden; Medical Oncology, Lund University, Lund, Sweden., El-Galaly T; Department of Hematology, Aalborg University Hospital, Aalborg., Kuitunen H; Cancer Centre, Oulu University Hospital, Oulu., Papworth K; Department of Radiation Sciences, Umeå University, Umeå, Sweden., Ljungqvist M; Department of Clinical Science and Education, Södersjukhuste, Karolinska Insitutet, Stockholm, Sweden; Haematology Centre, Karolinska University Hospital, Stockholm, Sweden., Pedersen MB; Department of Haematology, Aarhus University Hospital, Aarhus., Pollari M; Research Programs Unit/Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Oncology, Tays Cancer Center, Tampere University Hospital, Tampere. marjukka.pollari@pirha.fi.
Publikováno v:
Haematologica [Haematologica] 2024 Jul 01; Vol. 109 (7), pp. 2359-2363. Date of Electronic Publication: 2024 Jul 01.
Autor:
Lia K; Vestre Viken, Bærum Hospital, Department of Oncology, Gjettum, Norway; Faculty of Medicine, University of Oslo. kjerli@vestreviken.no., Jørgensen RRK; Clinical Cancer Research Centre, Aalborg University Hospital, Department of Hematology, Denmark; Aalborg University, Department of Clinical Medicine, Denmark., L Wold B; Oslo University Hospital, Department of Oncology., Fluge Ø; Haukeland University Hospital, Department of Oncology, Bergen., Fagerli UM; St. Olavs Hospital, Department of Oncology, Trondheim., Bersvendsen H; University Hospital of North Norway, Department of Oncology, Tromsø., Bø IB; Stavanger University Hospital, Department of Hematology., Bhargava S; Cancer Registry of Norway, Majorstuen, Oslo, Norway; Akershus University Hospital, Department of Oncology, Lørenskog., Fosså A; Oslo University Hospital, Department of Oncology, Norway; KG Jebsen Centre for B-cell Malignancies, University of Oslo, Oslo.
Publikováno v:
Haematologica [Haematologica] 2024 May 01; Vol. 109 (5), pp. 1403-1412. Date of Electronic Publication: 2024 May 01.
Autor:
Husby T; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Postboks 8905, Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Johannessen K; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Postboks 8905, Trondheim, Norway., Berntsen EM; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Postboks 8905, Trondheim, Norway.; Department of Radiology and Nuclear Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Johansen H; Department of Radiology and Nuclear Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Giskeødegård GF; Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Karlberg A; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Postboks 8905, Trondheim, Norway.; Department of Radiology and Nuclear Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Fagerli UM; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Eikenes L; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Postboks 8905, Trondheim, Norway. live.eikenes@ntnu.no.
Publikováno v:
EJNMMI reports [EJNMMI Rep] 2024 Jan 31; Vol. 8 (1), pp. 2. Date of Electronic Publication: 2024 Jan 31.
Autor:
Eikeland SA; Department of Oncology, National Advisory Unit for Late Effects after Cancer Treatment, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Smeland KB; Department of Oncology, National Advisory Unit for Late Effects after Cancer Treatment, Oslo University Hospital, Oslo, Norway., Simensen VC; Department of Global Health, Division of Health Care Services, Norwegian Institute of Public Health, Oslo, Norway., Fagerli UM; Department of Oncology, St. Olav's Hospital, Trondheim, Norway.; Department of Cancer Research and Molecular Medicine, NTNU, Trondheim, Norway., Bersvendsen HS; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Kiserud CE; Department of Oncology, National Advisory Unit for Late Effects after Cancer Treatment, Oslo University Hospital, Oslo, Norway., Fosså A; Department of Medical Oncology and Radiotherapy, Oslo University Hospital, Oslo, Norway.
Publikováno v:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Jan; Vol. 62 (1), pp. 80-88. Date of Electronic Publication: 2023 Jan 30.
Autor:
Husby T; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Postboks, 8905, Trondheim, Norway.; Department of Oncology, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway., Johansen H; Department of Radiology and Nuclear Medicine, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway., Bogsrud TV; PET-Centre, University Hospital of North Norway, Tromsø, Norway.; PET-Centre, Aarhus University Hospital, Aarhus, Denmark., Hustad KV; Department of Radiology and Nuclear Medicine, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway., Evensen BV; Department of Radiology and Nuclear Medicine, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway., Boellaard R; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands.; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, University Medical Centers Amsterdam, VUMC, Amsterdam, The Netherlands., Giskeødegård GF; Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Fagerli UM; Department of Oncology, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Eikenes L; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Postboks, 8905, Trondheim, Norway. live.eikenes@ntnu.no.
Publikováno v:
BMC cancer [BMC Cancer] 2022 Nov 01; Vol. 22 (1), pp. 1117. Date of Electronic Publication: 2022 Nov 01.
Autor:
Smeland K; National Advisory Unit on Late Effects after Cancer Treatment, Department of Oncology, Oslo University Hospital, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo. knusme@ous-hf.no., Holte H; Department of Oncology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B cell malignancies, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo., Fagerli UM; Department of Oncology, St. Olavs Hospital, Trondheim, Norway; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim., Bersvendsen H; Department of Oncology, University Hospital of North Norway, Tromso., Hjermstad MJ; Regional Advisory Unit for Palliative Care and European Palliative Care Research Centre (PRC), Dept. of Oncology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo., Loge JH; Department of Behavioural Medicine, Faculty of Medicine, University of Oslo, Oslo., Murbrach K; Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo., Linnsund MD; Department of Pediatric and Adolescent Medicine, Akershus University Hospital, Lorenskog., Fluge O; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen., Stenehjem JS; Department of Research, Cancer Registry of Norway, Oslo., Lund MB; Department of Respiratory Medicine, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo., Kvaloy S; National Advisory Unit on Late Effects after Cancer Treatment, Department of Oncology, Oslo University Hospital, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo., Kiserud CE; National Advisory Unit on Late Effects after Cancer Treatment, Department of Oncology, Oslo University Hospital, Oslo.
Publikováno v:
Haematologica [Haematologica] 2022 Nov 01; Vol. 107 (11), pp. 2698-2707. Date of Electronic Publication: 2022 Nov 01.
Autor:
Husby T; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Postboks 8905, Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Johansen H; Department of Radiology and Nuclear Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Bogsrud T; PET-Centre, University Hospital of North Norway, Tromsø, Norway.; Aarhus University Hosipital, Aarhus, Denmark., Hustad KV; Department of Radiology and Nuclear Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Evensen BV; Department of Radiology and Nuclear Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Boellard R; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands.; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, University Medical Centers Amsterdam, VUMC, Amsterdam, The Netherlands., Giskeødegård GF; Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Fagerli UM; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Eikenes L; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Postboks 8905, Trondheim, Norway. live.eikenes@ntnu.no.
Publikováno v:
Annals of hematology [Ann Hematol] 2022 May; Vol. 101 (5), pp. 1077-1088. Date of Electronic Publication: 2022 Feb 16.
Autor:
Bersvendsen HS; Department of Oncology, University Hospital of North Norway, Tromsø, Norway. hanne.bersvendsen@unn.no.; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway. hanne.bersvendsen@unn.no., Haugnes HS; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway., Dahl AA; National Advisory Unit for Late Effects After Cancer, Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway., Fagerli UM; Department of Oncology, St. Olav's Hospital, Trondheim, Norway.; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Fluge Ø; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Holte H; Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.; K.G. Jebsen-Centre for B cell malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Seland M; National Advisory Unit for Late Effects After Cancer, Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway., Wilsgaard T; Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway., Smeland KB; National Advisory Unit for Late Effects After Cancer, Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway., Kiserud CE; National Advisory Unit for Late Effects After Cancer, Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2020 May; Vol. 55 (5), pp. 891-905. Date of Electronic Publication: 2019 Nov 19.